Company Profile
Updated: 24-MAR-09Biofrontera AG
International public company
Hemmelrather Weg 201, Leverkusen, D-51377, Germany
()49 0214 8 76 32 0, 49 0214 8 76 32 90 fax, http://www.biofrontera.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Biotechnology company engaged in developing new methods to expedite drug discovery and to apply these methods to medical problems, particularly to disorders of the nervous system
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
DNAPrint's $35M Stock Sale Will Finance German Buy-In.
BIOWORLD Today; 11/3/2009; 1071 words; ...Germany-based pharmaceutical firm Biofrontera AG. "It's a different approach...6 million) over 24 months in Biofrontera's Series B preferred shares...is exceptionally high." The Biofrontera deal gives DNAPrint shareholders...
Other News To Note.
BIOWORLD Today; 11/3/2009; 2307 words; ...Fla., said it acquired an 18 percent stake in Biofrontera AG, of Leverkusen, Germany, for /1.5 million...Richard Gabriel and Hector Gomez, remain on the Biofrontera board. Biofrontera is in Phase II trials with its BF-Derml product...
German Biofrontera completes capital increase.
ADP Debt News; 9/10/2009; 377 words; ...ADPnews) - Sep 10, 2009 - German biotechnology firm Biofrontera AG (ETR:B8F) has successfully completed a capital...base capital will increase to EUR 7.34 million. Biofrontera will use the proceeds from the capital hike to reach...
Allegiance Equity Corporation: Update on Trading Halt and License Agreement.
Canadian Corporate News; 5/22/2009; 856 words; ...terminated its license agreement with Biofrontera AG whereby Prime Pharmaceutical had...Relieva(R) and Psorerine(R) to Biofrontera AG. The license agreement was terminated as a result of Biofrontera AG failing to meet its obligations...
Biofrontera AG-Company Report.
M2 Presswire; 2/4/2009; 494 words; ...4 February 2009-www.companiesandmarkets.com: Biofrontera AG-Company Report(C)1994-2009 M2 COMMUNICATIONS...www.companiesandmarkets.com adds new report: Biofrontera AG-Company Report Private Company Reports provide up...
Recent News Articles
- Appointments at Biofrontera AG.(Biofrontera Pharmaceuticals GmbH appointed Werner Pehlemann )(Brief Article)
Pharma Marketletter - February 06, 2006 - DNAPrint(TM) genomics, Inc. Agrees to Acquire Majority Ownership in German Pharmaceutical Company Biofrontera AG; Secures $35 Million Equity Commitment from Dutchess Private Equities Fund, L.P.
PR Newswire - September 28, 2004
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
